Neoplasms

All Conditions

Symptoms and General Pathology

Gland and Hormone Related Diseases

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Diseases and Abnormalities at or Before Birth

Nutritional and Metabolic Diseases

Rare Diseases

Carcinoma

Adenoma

Syndrome

Adrenal Insufficiency

Cushing Syndrome

Pheochromocytoma

Hyperplasia

Hyperaldosteronism

Adrenocortical Adenoma

Adrenocortical Carcinoma

Adrenal Gland Diseases

Adrenal Hyperplasia, Congenital

Adrenogenital Syndrome

Hypoaldosteronism

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Paraganglioma

Neuroendocrine Tumors

Neuroectodermal Tumors

Neuroectodermal Tumors, Primitive

Neoplasms, Germ Cell and Embryonal

Neoplasms, Nerve Tissue

Adrenocortical Hyperfunction

Endocrine System Diseases

Disorders of Sex Development

Congenital Abnormalities

Urogenital Abnormalities

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Male Urogenital Diseases

Genetic Diseases, Inborn

Metabolism, Inborn Errors

Steroid Metabolism, Inborn Errors

Metabolic Diseases

Gonadal Disorders

Adrenal Cortex Neoplasms

Adrenal Gland Neoplasms

Endocrine Gland Neoplasms

Adrenal Cortex Diseases

Cushing's Syndrome

Adenoma of the Adrenal Gland

Congenital Adrenal Hyperplasia

21-hydroxylase Deficiency

Paragangliomas 1

Neuroendocrine Tumor

Neuroepithelioma

Hyperadrenalism

Vasoconstrictor Agents

Respiratory System Agents

All Drugs and Chemicals

Epinephrine

Racepinephrine

Epinephryl borate

shouyue SUN, MD

Epidemiologic studies have revealed a tremendous increase in the prevalence of adrenal associated disease and related mortality worldwide. In order to meet all the therapeutic challenges in adrenal disease in China, CASE was founded in 2020. The objective of CASE is to launch an adrenal disease management model based on the Internet health information platform which allows the application and evaluation of adrenal disease treatment strategies at multiple centers. The proprietary electronic medical database will help the dynamic big-data analysis in epidemiology of adrenal disease, diagnosis, and treatment.

In order to meet all the challenges in the diagnosis and treatment of adrenal diseases in China, CASE was founded in 2020. With advanced medical equipment and Internet of Things (IoT) technology, CASE is committed to creating an online and offline integrated solution for adrenal disease, and for the entire spectrum of adrenal disease, to achieve a more convenient and precise model of care for patients, aiming to establish a platform with diagnosis and treatment of adrenal disease and their long-term follow-up. It allows the application and evaluation of treatment strategies at these centers.

China Adrenal Disease Registry

China Adrenal Disease Registry Study

The symptom checklist-90 will be used to evaluate the changes of participants' psychological state through study completion from 10 aspects, including somatization, obsessive-compulsive symptoms, interpersonal sensitivity, depression, anxiety, hostility, terror, paranoia, psychotic and others.

Shanghai Jiao Tong University School of Medicine

Director, Head of Endocrinology, Principal Investigator, Clinical Professor

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
China Adrenal Disease Registry	NCT04890444	Cushing Syndrom... Aldosteronism Hypoadrenalism Congenital Adre... Adrenal Adenoma Adrenal Inciden... Adrenal Carcino... Pheochromocytom...		16 Years - 75 Years	Shanghai Jiao Tong University School of Medicine
China Adrenal Disease Registry	NCT04890444	Cushing Syndrom... Aldosteronism Hypoadrenalism Congenital Adre... Adrenal Adenoma Adrenal Inciden... Adrenal Carcino... Pheochromocytom...		16 Years - 75 Years	Shanghai Jiao Tong University School of Medicine

Spots Global Cancer Trial Database for congenital adrenal hyperplasia